Refine
Document Type
- Article (3)
- Preprint (2)
- Doctoral Thesis (1)
Has Fulltext
- yes (6)
Is part of the Bibliography
- no (6)
Keywords
- Aortic valve (1)
- B cell receptor (1)
- Blood pressure (1)
- Body mass index (1)
- Chronic obstructive pulmonary disease (1)
- Death rates (1)
- Drug screens (1)
- Ejection fraction (1)
- Heart failure (1)
- Hematology (1)
Institute
- Medizin (5)
- Sportwissenschaften (1)
As new generations of targeted therapies emerge and tumor genome sequencing discovers increasingly comprehensive mutation repertoires, the functional relationships of mutations to tumor phenotypes remain largely unknown. Here, we measured ex vivo sensitivity of 246 blood cancers to 63 drugs alongside genome, transcriptome, and DNA methylome analysis to understand determinants of drug response. We assembled a primary blood cancer cell encyclopedia data set that revealed disease-specific sensitivities for each cancer. Within chronic lymphocytic leukemia (CLL), responses to 62% of drugs were associated with 2 or more mutations, and linked the B cell receptor (BCR) pathway to trisomy 12, an important driver of CLL. Based on drug responses, the disease could be organized into phenotypic subgroups characterized by exploitable dependencies on BCR, mTOR, or MEK signaling and associated with mutations, gene expression, and DNA methylation. Fourteen percent of CLLs were driven by mTOR signaling in a non–BCR-dependent manner. Multivariate modeling revealed immunoglobulin heavy chain variable gene (IGHV) mutation status and trisomy 12 as the most important modulators of response to kinase inhibitors in CLL. Ex vivo drug responses were associated with outcome. This study overcomes the perception that most mutations do not influence drug response of cancer, and points to an updated approach to understanding tumor biology, with implications for biomarker discovery and cancer care.
BACKGROUND: The AGO-ETC trial compared 5-year relapse-free survival of intense dose-dense (IDD) sequential chemotherapy with epirubicin (E), paclitaxel (T), and cyclophosphamide (C) (IDD-ETC) every 2 weeks vs conventional scheduled epirubicin/cyclophosphamide followed by paclitaxel (EC→T) (every 3 weeks) as adjuvant treatment in high-risk breast cancer patients. The objective of this study was to evaluate the safety and efficacy of epoetin alfa in a second randomization of the intense dose-dense arm.
METHODS: One thousand two hundred eighty-four patients were enrolled; 658 patients were randomly assigned to the IDD-ETC treatment group. Within the IDD-ETC group, 324 patients were further randomly assigned to the epoetin alfa group, and 319 were randomly assigned to the non-erythropoiesis-stimulating agent (ESA) control group. Primary efficacy endpoints included change in hemoglobin level from baseline to Cycle 9 and the percentage of subjects requiring red blood cell transfusion. Relapse-free survival, overall survival, and intramammary relapse were secondary endpoints estimated with Kaplan-Meier and Cox regression methods. Except for the primary hypothesis, all statistical tests were two-sided.
RESULTS: Epoetin alfa avoided the decrease in hemoglobin level (no decrease in the epoetin alfa group vs -2.20g/dL change for the control group; P < .001) and statistically significantly reduced the percentage of subjects requiring red blood cell transfusion (12.8% vs 28.1%; P < .0001). The incidence of thrombotic events was 7% in the epoetin alfa arm vs 3% in the control arm. After a median follow-up of 62 months, epoetin alfa treatment did not affect overall survival, relapse-free survival, or intramammary relapse.
CONCLUSIONS: Epoetin alfa resulted in improved hemoglobin levels and decreased transfusions without an impact on relapse-free or overall survival. However, epoetin alfa had an adverse effect, resulting in increased thrombosis.
Aims: Patients with aortic stenosis (AS) may have concomitant heart failure (HF) that determines prognosis despite successful transcatheter aortic valve implantation (TAVI). We compared outcomes of TAVI patients with low stroke volume index (SVI) ≤35 ml/m2 body surface area in different HF classes.
Methods and results: Patients treated by transfemoral TAVI at our center (n = 1822) were classified as 1) ‘HF with preserved ejection fraction (EF)’ (HFpEF, EF ≥50%), 2) ‘HF with mid-range EF’ (HFmrEF, EF 40–49%), or 3) ‘HF with reduced EF’ (HFrEF, EF <40%). Patients with SVI >35 ml/m2 served as controls. The prevalence of cardiovascular disease and symptoms increased stepwise from controls (n = 968) to patients with HFpEF (n = 591), HFmrEF (n = 97), and HFrEF (n = 166). Mortality tended to be highest in HFrEF patients 30 days post-procedure, and it became significant after one year: 10.2% (controls), 13.5% (HFpEF), 13.4% (HFmrEF), and 23.5% (HFrEF). However, symptomatic improvement in survivors of all groups was achieved in the majority of patients without differences among groups.
Conclusions: Patients with AS and HF benefit from TAVI with respect to symptom alleviation. TAVI in patients with HFpEF and HFmrEF led to an identical, favorable post-procedural prognosis that was significantly better than that of patients with HFrEF, which remains a high-risk population.
Es wird allgemein vermutet, dass Klassenfahrten bei den Schülern nachhaltige Veränderungen bewirken können und nur wenige empirische Befunde belegen die Wirksamkeit von Klassenfahrten. Diese defizitäre Forschungslage aufgreifend, beschäftigt sich die vorliegende Arbeit mit der sozial-integrativen Wirkung einer sportbezogenen Klassenfahrt (Skifahrt) auf empirischer Grundlage.
Mit Hilfe der Desintegrationstheorie von Anhut & Heitmeyer (2000) lässt sich das Konstrukt „Integration“ in allgemeinerer Form über das antinomische Begriffspaar „Anerkennung vs. Ablehnung“ operationalisieren, wobei zwischen positionaler, moralischer und emotionaler Anerkennung bzw. Ablehnung unterschieden werden kann. Neben individuellen Merkmalen erfolgt die Vergabe und Verweigerung von Anerkennung über kollektive Merkmale, die auf Zugehörigkeit zu einer Gruppe beruht. Im pädagogischen Kontext der Schulklasse ist daher von besonderem Interesse, wie sich die Anerkennungsverhältnisse zwischen Gruppen verändern, denen besondere Potenziale für heterogenitätsbedingte Ablehnung zugeschrieben wird (vgl. Gerecke, 2010). Hypothetisch sind dies Mädchen „vs.“ Jungen, Jugendliche mit „vs.“ Jugendliche ohne Migrationshintergrund und bezüglich Klassenfahrten die Gruppe der Schüler, die nicht teilnehmen konnten „vs.“ der Gruppe derer, die teilgenommen haben. Auf dieser Grundlage beschäftigt sich die vorliegende Arbeit mit den Effekten sportbezogenen Klassenfahrten auf die soziale Integration operationalisiert in Anerkennungsverhältnissen.
Mittels eines soziometrischen Wahlverfahrens wurden die Anerkennungs- und Ablehnungsverhältnisse von vier Schulklassen (N=95) zu drei Messzeitpunkten (Eingangs-, Ausgangs- und Behaltenstest nach sechs Wochen) computergestützt erhoben.
Die Betrachtung der Gesamtgruppe zeigt eine Steigerung der positiven Wahlen (eta²=0,210) bei einer gleichzeitigen Reduktion der negativen Wahlen (eta²=0,167). Diese Entwicklung ist über Post-hoc-Einzelvergleiche auf eine signifikante Veränderung innerhalb des Treatmentzeitraumes (ET AT) zurückzuführen. Das Intervall AT-BT nach Abschluss der Klassenfahrt ist nicht signifikant, so dass auf eine zeitliche Stabilität der Ergebnisse geschlossen werden kann. Allerdings sind große Unterschiede zwischen den einzelnen Klassen festzustellen, die nicht teilweise nicht mit dem Gesamtergebnis übereinstimmen. In der differenzierten Betrachtung der heterogenitätsbedingten Unterschiede ist in erster Linie ein Geschlechtereffekt zu erkennen. Insbesondere die positiven und negativen Wahlen zwischen Schülern verschiedenen Geschlechts verändern sich signifikant. Aber auch hier zeigen sie die bereits dargestellten klassenspezifischen Differenzen.
Während der Teilnahmestatus keinen Einfluss auf die Vergabe von negativen und positiven Wahlen besitzt, beeinflusst der Migrationsstatus hingegen die positiven Wahlen signifikant.
Mit Blick auf die theoretischen Grundlagen dieser Arbeit kann der Anstieg der positiven Wahlen als Zuwachs von Anerkennung und der Rückgang negativer Wahlen als eine Reduktion von Ablehnung interpretiert werden, wobei sich kein einheitliches Bild auf Klassenebene ergibt.
Anhut, R. & Heitmeyer, W. (2000). Desintegration, Konflikt und Ethnisierung. Eine Problemanalyse und theoretische Rahmenkonzeption. In W. Heitmeyer (Hrsg.), Bedrohte Stadtgesellschaft. Soziale Desintegrationsprozesse und ethnisch-kulturelle Konfliktkonstellationen (S. 17–73). Weinheim: Juventa-Verlag.
Gerecke, P. (2010). Heterogenitätsbedingte Unterschiede zwischen Ingroup- und Outgroup-Anerkennung bzw. -Ablehnung im Sportunterricht. Eine empirische Studie zum integrativen Einfluss des Kooperativen Lernens. Dissertation. Frankfurt am Main: Johann-Wolfgang Goethe Universität.
Background Vasoplegic syndrome is frequently observed during cardiac surgery and resembles a complication of high mortality and morbidity. There is a clinical need for therapy and prevention of vasoplegic syndrome during complex cardiac surgical procedures. Therefore, we investigated different strategies in a porcine model of vasoplegia.
Methods We evaluated new medical therapies and prophylaxis to avoid vasoplegic syndrome in a porcine model. After induction of anesthesia, cardiopulmonary bypass was established through median sternotomy and central cannulation. Prolonged aortic cross-clamping (120 min) simulated a complex surgical procedure. The influence of sevoflurane-guided anesthesia (sevoflurane group) and the administration of glibenclamide (glibenclamide group) were compared to a control group, which received standard anesthesia using propofol. Online hemodynamic assessment was performed using PiCCO® measurements. In addition, blood and tissue samples were taken to evaluate hemodynamic effects and the degree of inflammatory response.
Results Glibenclamide was able to break through early vasoplegic syndrome by raising the blood pressure and systemic vascular resistance as well as less need of norepinephrine doses. Sevoflurane reduced the occurrence of the vasoplegic syndrome in the mean of stable blood pressure and less need of norepinephrine doses.
Conclusion Glibenclamide could serve as a potent drug to reduce effects of vasoplegic syndrome. Sevoflurane anesthesia during cardiopulmonary bypass shows less occurrence of vasoplegic syndrome and therefore could be used to prevent it in high-risk patients.
Clinical Perspective; what is new?
* to our knowledge, this is the first randomized in vivo study evaluating the hemodynamic effects of glibenclamide after the onset of vasoplegic syndrome
* furthermore according to literature research, there is no study showing the effect of sevoflurane-guided anesthesia on the occurrence of a vasoplegic syndrome
Clinical Perspective; clinical implications?
to achieve better outcomes after complex cardiac surgery there is a need for optimized drug therapy and prevention of the vasoplegic syndrome
Improved integration of single cell transcriptome data demonstrated on heart failure in mice and men
(2023)
Biomedical research frequently uses murine models to study disease mechanisms. However, the translation of these findings to human disease remains a significant challenge. In order to improve the comparability of mouse and human data, we present a cross-species integration pipeline for single-cell transcriptomic assays.
The pipeline merges expression matrices and assigns clear orthologous relationships. Starting from Ensembl ortholog assignments, we allocated 82% of mouse genes to unique orthologs by using additional publicly available resources such as Uniprot, and NCBI databases. For genes with multiple matches, we employed the Needleman-Wunsch global alignment based on either amino acid or nucleotide sequence to identify the ortholog with the highest degree of similarity.
The workflow was tested for its functionality and efficiency by integrating scRNA-seq datasets from heart failure patients with the corresponding mouse model. We were able to assign unique human orthologs to up to 80% of the mouse genes, utilizing the known 17,492 orthologous pairs. Curiously, the integration process enabled the identification of both common and unique regulatory pathways between species in heart failure.
In conclusion, our pipeline streamlines the integration process, enhances gene nomenclature alignment and simplifies the translation of mouse models to human disease. We have made the OrthoIntegrate R-package accessible on GitHub (https://github.com/MarianoRuzJurado/OrthoIntegrate), which includes the assignment of ortholog definitions for human and mouse, as well as the pipeline for integrating single cells.